close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.41 +0.09 (+0.33%)
Official Closing Price Updated: 7:00 PM EDT, Mar 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
They aren't just "pandemic stocks." 
Via The Motley Fool
Topics Intellectual Property
Which S&P500 stocks are the most active on Thursday? ↗
Via Chartmill
News headline image
Follow the Footprints: 3 Stocks with Unusual Options Activity That You Can’t Ignore
On a day when nothing worked for investors, yesterday’s unusual options activity had plenty of variety, especially in the top three. Here’s how investors might have played each of the stock's and their... 
Via Barchart.com
Topics Economy Stocks
News headline image
Is It Too Late to Buy Eli Lilly? ↗
Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Looking for Safety and Yield as Oil Prices Whip Saw? This Stock Has You Covered.
As oil prices rise with increasing global uncertainty, this pharmaceutical stock emerges as a possible safe haven for income investors. 
Via Barchart.com
Topics Earnings
News headline image
Pfizer Combo Therapy Scores Major Win In Prostate Cancer Trial ↗
Pfizer (PFE) shares rise as Talzenna/Xtandi combo hits primary goal in Phase 3 prostate cancer trial. See the full TALAPRO-3 results. 
Via Benzinga
Looking for the most active stocks in the S&P500 index on Wednesday? ↗
Via Chartmill
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
The Best Healthcare Stocks to Buy With $50 Right Now ↗
Even on a budget, you can get quality stocks. 
Via The Motley Fool
News headline image
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Tuesday's session: most active stock in the S&P500 index ↗
Via Chartmill
News headline image
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17,... 
Via MarketMinute
Topics Earnings Economy Initial Public Offering
News headline image
Pfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients ↗
Pfizer trial results for a new breast cancer treatment showed improved progression-free survival and a manageable safety profile. 
Via Benzinga
News headline image
Should You Avoid Pfizer? Here's the Key Risk to Watch ↗
Pfizer has reached a turning point. 
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper... 
Via MarketMinute
Topics Artificial Intelligence Initial Public Offering Stocks
News headline image
VCIT Offers Broader Diversification Than FIGB ↗
Explore how differences in cost, risk, and portfolio breadth could impact your choice between these two bond ETFs. 
Via The Motley Fool
Topics Bonds ETFs
News headline image
Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 Monster Dividend Stocks to Hold for the Next 10 Years ↗
These dividend stocks are built for the long haul. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
The Stock Market May Be Shifting From Risky Tech Stocks to Safer Sectors. Here Are 3 Stocks to Buy Before They Soar. ↗
Plenty of companies do just fine regardless of the economic environment. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
1 Magnificent Dividend Stock Down 57% to Buy and Hold Forever ↗
This healthcare giant is trading at a discounted price today. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se... 
Via StockStory
News headline image
Starboard Value Is Betting Big on This Blue-Chip Dividend Stock. Should You?
Starboard does not have a stellar recent record, and Lamb Weston is facing its own issues. Here's what investors need to know about Lamb Weston. 
Via Barchart.com
News headline image
Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
Date: March 12, 2026 Introduction Dianthus Therapeutics (NASDAQ: DNTH) has become the center of Wall Street’s attention today, with its share price surging 19.4% in early trading following a pivotal... 
Via Finterra
Topics Economy
News headline image
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
Date: March 12, 2026Sector: Biotechnology / NeurologyMarket Cap: ~$4.8 Billion Introduction On March 9, 2026, the neurology sector of the biotechnology market witnessed a seismic shift. Xenon... 
Via Finterra
Topics ETFs Intellectual Property
News headline image
The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income
Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start. Pfizer (PFE) has been a strong performer in 2026 and is up 9.64% so far this... 
Via Barchart.com
Stay informed about the most active stocks in the S&P500 index on Wednesday's session. ↗
Via Chartmill
News headline image
Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up ↗
Shares popped Tuesday on a notable shake-up in the patent battle surrounding Pfizer's rival drug, tafamidis. 
Via Investor's Business Daily
Topics Intellectual Property
News headline image
2 Healthcare Stocks That Are Too Cheap to Ignore ↗
These companies' shares have fallen too far, offering investors an attractive opportunity. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today